Impact Therapeutics

Founded 2009 · $30.0M raised

Founded
2009
Business Model
B2B
Total Funding
$30.0M
Last Round
$30.0M Series CAug 2018
Rounds
1

About

IMPACT Therapeutics is a commercial-stage biotechnology company focused on advancing synthetic lethality (SL)-based precision anti-cancer therapies globally to meet cancer patients' unmet medical needs. The company discovers and develops targeted anti-cancer therapies and is actively advancing the clinical and regulatory development of senaparib, including a Marketing Authorisation Application in Europe. IMPACT has also nominated IMP2794 as a preclinical candidate, a highly KAT6A-specific PROTAC from its proprietary targeted protein degradation platform.

Summary

Impact Therapeutics is a Biotech company, founded in 2009. It has raised $30.0M in total across 1 round, most recently a $30.0M Series C round in Aug 2018. Investors include Decheng Capital and Lilly Asia Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CAug 2018
$30.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Impact Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/impact-therapeutics"><img src="https://indexed.vc/api/badge/company/impact-therapeutics" alt="Impact Therapeutics on Indexed.vc" width="260" height="76" /></a>